Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'The Pharmaceutical Company Outlook to : Financial and Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech' returned 3 results - Page 1 of 1  FEATURED RESULTS Marketing and Sales Organization Best Practices for Biotech ... European Biotech Industry Guide 2007, 5th Ed Animal Biotechnology - Technologies, Markets and Companies European Biotech Industry Guide 2007, 5th Ed Portfolio, Program, and Project Management in the Pharmaceut...   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases   Decision Resources, Inc., July 2009, Pages: 43 . 200 deals: Total deal volume; biobucks; 20 largest deals; Big Biotech, Mid-Size Pharma and Big Pharma deals; most active disease areas; most active companies; top five deals by technology, outlicensing Global Biopharma Outlook 2011   MP Advisors, Jan 2011, Pages: 391 US, EU, Japan and ROW companies – formulated with an aim to facilitate strategic and long term investment decision making of senior management. Outlook-11' has been tailored to deliver more M&A Trends in Pharma   Datamonitor, Oct 2008, Pages: 144 &As targeted primarily cardiovascular-focused companies, 2006-mid-2008 83 Figure 26: Big Pharmas and mid pharmas M&As targeted primarily oncology companies if biotech are included in the analysis by therapy area Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network